239463-85-5

• 常用中文名：5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐
• 常用英文名：5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate
• CAS号：239463-85-5
• 分子式：C₂₆H₃₁N₃O₈
• 分子量：513.540
• 发布时间：2018-12-31 19:02:12
• 更新时间：2026-07-08 12:42:21

名称

• 中文名: 5-[(2R)-2-氨基丙基]-1-[3-(苯甲酰氧基)丙基]-2,3-二氢-7-氰基-1H-吲哚酒石酸盐
• 英文名: 3-[5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydroindol-1-yl]propyl benzoate,(2R,3R)-2,3-dihydroxybutanedioic acid
• 中文别名: 西洛多辛酒石酸盐; 5-[(2R)-2-氨基丙基]-1-[3-(苯甲酰氧基)丙基]-2,3-二氢-7-氰基-1; 5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石; 5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐(西洛多辛中间体); 5-[(2R)-2-氨基丙基]-1-[3-(苯甲酰基)丙基]-2,3-二氢-1H-吲哚-7碳腈L-酒石酸盐; (R) -3-(5-(2-氨基丙基)-7-氰基吲哚啉-1-基)苯甲酸丙酯(2R,3R)-2,3-二羟基琥珀酸酯; 西罗多辛中间体B 5-[(2R)-2-氨基丙基]-2,3- 二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石; 西罗多辛中间体B; 6-西洛多辛主链; 西洛多辛主环; 西洛多辛化合物B (酒石酸盐）; 5-[(2R)-2-氨基丙基]-1-[3-(苯; 5-[(2R)-2-氨基丙基]-2; 5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐西洛多辛(赛洛多辛)中间体; 西洛多辛中间体二; 西洛多辛主链; 西洛多辛中间体B(化合物B); 西洛多辛中间体B; 5-[2R-2-氨基丙基]-1-[3-苯甲酰氧基丙基]-2,3-二氢-1H-吲哚-7-甲腈; 西罗多辛中间体B5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐; 3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐; 239-5 5-[(2R)-2-氨基丙基]-2,3- 二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐; 西洛多辛中间体B5-[(2R)-2-氨基丙基]-2,3-二氢-1-[3-(苯甲酰氧基)丙基]-1H-吲哚-7-腈酒石酸盐; 5-[(2R)-2-氨基丙基]-1-[3-(苯甲酰基氧基)丙基]-2,3-二氢-1H-吲哚-7-甲腈 (2R,3R)-2,3-二羟基丁二酸
• 英文别名: (R)-5-(2-aminopropyl)-1-(3-benzoyloxypropyl) Indoline-7-Carbonitrile Tartaric acid; 5-[(2R)-2-AMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H; 5[(2R)2Aminopropyl]1[3(benzoyloxy)propyl]2,3dihydro1Hindole7cbonitrile (2R,3R)2,3dihydroxybutanedioate,5 [(2R) 2 Aminopropyl] 1 [3 (benzoyloxy)propyl] 2,3 dihydro 1H indole 7 carbonitrile (2R,3R) 2,3 dihydroxybutanedioate; 3-dihydroxybutanedioate; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate(For export only); 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7cbonitrile L-ttrate; 5-[(2R)-2-aminopropyl]-1-[3-(benzyloxy)propyl]-2,3-dihydro-7-carbonitrile-1H-indole(2R,3R)-2,3-dihydroxy butanedioate; 1-(3-benzoyloxypropyl)-7-cyano-5-(2-aminopropyl)-2,3-dihydroindole; Silodoxin intermediate b; 5-((2R)-2-AMINOPROPLY)-1-(3-(BENZYLOXY)PROPYL)-2,3-DIHYDRO-7-CBONOTRILE-1H-INDOLE-(2R,3R)-2,3-DIHYDROBUTANEDIOATE (ACI; 3-dihydro-1H-indole-7-carbonitrile (2R; 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-7-carbonitrile-1H-indole (2R,3R)-2,3-dihydroxybutanedioate (1:1); (R)-5-(2-aminopropyl)-1-(3-benzoyloxypropyl) Indoline-7-carbonitrile Ttic acid; (R)-3-(5-(2-Amino-propyl)-7-cyanoindolin-1-yl)-propyl benzoate L-(+)-ttrate; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate, 10 mM in DMS; 3-(5-((R)-2-Aminopropyl)-7-Cyanoindolin-1-yl)propyl benzoate L-Ttrate; 5-[(2R)-2-aMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-Indole-7-carbonitrile ttate; 5-[(2R)-2-AMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dih; 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-Indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI ACI); 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioat; 239-5 5- [(2R) -2-aminopropyl] -2,3-dihydro-1- [3- (benzoyloxy) propyl] -1H-indole-7-nitrile ttrate; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3- dihydro-1H- indole-7-carbonitrile (2R,3R)-2,3; Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (1:1); 3-[5-[(2R)-2-Aminopropyl]-7-cyano-indolin-1-yl]propyl benzoate; (2R,3R)-2,3-Dihydroxysuccinic acid - 3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate (1:1); 5-[(2R)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CBO; 5-[(2R)-2-aMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate (1:1); (R)-3-(5-(2-Aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate (2R,3R)-2,3-dihydroxysuccinate; 5-[(2R)-2-aMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-7-carbonitrile -1H-indole (2R,3R)-2,3-dihydroxybutanedioate; 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(benzoyloxy)propyl]-1H-indole-7-cbonitrilettrate; 3-(5-(2-Aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate (2R,3R)-2,3-dihydroxysuccinate; Silodosin KSM-1; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2, 3-dihydroxybutanedioate(for Silodoxin); 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indol-7-carbonitrile; Silodosin pent nucleus; 5_[(2R)-2-aminopropyl]-l-[3-(benzoyloxy)propyll-2,3-dihydro-7-carbonitrile; Silodosin Intermediates; (R)-5-(2-aminopropyl)-1-(3-benzyloxypropyl) indoline-7-carbonitrile ttic acid; 5-[(2R)-2-AMinopropyl]-1-[3-(benzoyloxy)propyl] -2,3-dihydro-1H-indole-7-carbonitrile; 5-[(2R)-2-AMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioa; 1H-Indole-7-carbonitrile, 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-, (2R,3R)-2,3-dihydroxybutanedioate; R)-5-(2-aMinopropyl)-1-(3-benzyloxypropyl) indoline-7-carbonitrile ttrate; (R)-3-(5-(2-Aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate (2R,3R)-2,3-dihydroxysuccinate (Intermediate of Silodosin); 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro; 5-[(2R)-2-aMinopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-7-carbonitrile-1H-indole(2R,3R)-2,3-dihydroxybutanedioat; 3-{5[(2R)-2-aminoprppyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate monotartaric acid salt; Silodosin Impurity 9; (R)-3-(5-(2-aMinopropyl)-7-cyanoindolin-1-yl)propyl benzoate (2R,3R)-2,3-dihydroxysuccinate; Silodosin inetermediate; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate###239-5; 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R); 3-(5-((R)-2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate L-tartrate; 1H-Indole-7-carbonitrile, 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI, ACI); 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile(2R,3R)-2,3-dihydroxybutanendioate; 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(benzoyloxy)propyl]-1H-indole-7-cbonitrilettrate(SilodosinIntermediateB)

物化性质

• 分子式: C₂₆H₃₁N₃O₈
• 分子量: 513.540
• 精确质量: 513.211121
• PSA: 194.41000
• LogP: 1.70028
• 储存条件: 室温，干燥

上下游产品

上游产品  3
87-69-4 1338365-54-0 350797-56-7
下游产品  0